BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15237276)

  • 1. Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides.
    Michaelis S; Cozzio A; Kempf W; Graf P; Burg G; Dummer R
    Dermatology; 2004; 209(1):72-4. PubMed ID: 15237276
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
    Coors EA; Von den Driesch P
    Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
    [No Abstract]   [Full Text] [Related]  

  • 5. Combining rexinoids with psoralen-ultraviolet A sheds light on the management of mycosis fungoides.
    Ahmed Z; Piguet V
    Br J Dermatol; 2012 Sep; 167(3):467. PubMed ID: 22924948
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
    Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
    Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet bath therapy.
    Huber MA; Kunzi-Rapp K; Staib G; Scharffetter-Kochanek K
    J Am Acad Dermatol; 2004 Mar; 50(3):475-6. PubMed ID: 14988696
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
    Talpur R; Duvic M
    Clin Lymphoma Myeloma; 2006 May; 6(6):488-92. PubMed ID: 16796781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular mycosis fungoides: successful treatment with oral bexarotene.
    Shistik G; Scalf LA; Fenske N; Glass LF
    J Drugs Dermatol; 2004; 3(3):301-4. PubMed ID: 15176165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
    Huang J; Cowper S; Moss J; Girardi M
    J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of multiple basal cell carcinomas in mycosis fungoides treated with oral bexarotene.
    Calzavara-Pinton P; Leali C; Venturini M; Sala R; Zane C
    Eur J Dermatol; 2007; 17(4):341-2. PubMed ID: 17540649
    [No Abstract]   [Full Text] [Related]  

  • 12. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
    Coors E
    Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
    Papadavid E; Antoniou C; Nikolaou V; Siakantaris M; Vassilakopoulos TP; Stratigos A; Stavrianeas N; Katsambas A
    Am J Clin Dermatol; 2008; 9(3):169-73. PubMed ID: 18429646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
    Wirtz M; Helbig D
    Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
    Dalle S; Thomas L
    Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
    [No Abstract]   [Full Text] [Related]  

  • 17. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate.
    Steinhoff M; Beyer M; Roewert-Huber J; Lukowsky A; Assaf C; Sterry W
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S88-91. PubMed ID: 18489056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycosis fungoid treated with oral bexarotene: study of 13 cases].
    Roche Gamón E; Pérez Ferriols A; Vilata Corell JJ; Alegre de Miquel V
    Med Clin (Barc); 2007 Nov; 129(17):677. PubMed ID: 18005638
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome.
    Tsirigotis P; Pappa V; Papageorgiou S; Kapsimali V; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Stavrianeas N; Economopoulos T; Dervenoulas J
    Br J Dermatol; 2007 Jun; 156(6):1379-81. PubMed ID: 17459033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.